Table 4.
Unadjusted |
Adjusted |
|||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Patient Characteristics | ||||
Admission Period | ||||
Pre-Lockdown | 1.00 | |||
Post-Lockdown | 3.11 (1.08,9.00) | 0.036 | 1.20 (0.22,6.56) | 0.830 |
Age | 1.07 (1.03,1.11) | 0.001 | 1.05 (0.98,1.12) | 0.206 |
Gender | ||||
Male | 1.00 | |||
Female | 1.75 (0.55,5.64) | 0.346 | ||
Ethnicity | ||||
White | 1.00 | |||
BAME | 0.00 (0.00,0.00) | 0.999 | ||
Deprivation Quintile | ||||
1 (Most) | 1.00 | |||
2 | 0.23 (0.03,1.80) | 0.160 | ||
3 | 0.44 (0.06,3.60) | 0.446 | ||
4 | 0.39 (0.05,3.16) | 0.379 | ||
5 (Least) | 0.63 (0.13,3.01) | 0.565 | ||
Charlson Comorbidity Score | 1.14 (1.07,1.21) | <0.001 | 1.19 (1.07,1.32) | 0.001 |
Hypertensive | 2.76 (0.94,8.06) | 0.064 | 0.77 (0.11,5.24) | 0.786 |
Pre-existing Respiratory Disease | 0.76 (0.17,3.49) | 0.727 | ||
Diabetes Mellitus | 2.49 (0.75,8.21) | 0.135 | 1.73 (0.27,10.9) | 0.562 |
Heart Failure | 4.41 (1.13,17.2) | 0.033 | 1.57 (0.15,16.2) | 0.707 |
Obesity (BMI >30) | 0.36 (0.08,1.63) | 0.186 | ||
Chronic Kidney Disease | 4.41 (1.13,17.2) | 0.033 | 0.24 (0.02,3.05) | 0.269 |
ASA Classification | ||||
1 | 1.00 | |||
2 | 2.07 (0.37,11.6) | 0.408 | ||
3 | 13.8 (3.41,56.1) | <0.001 | 1.84 (0.09,37.5) | 0.693 |
4 | 16.6 (2.53,108) | 0.003 | 1.79 (0.43,2.48) | 0.464 |
COVID-19 Diagnosis | 0.00 (0.00,0.00) | 0.999 | ||
Clinical Condition | ||||
NEWS Score (Admission) | 1.64 (1.32,2.05) | <0.001 | 1.80 (1.25,2.58) | 0.001 |
White Cell Count (Admission) | 1.17 (1.08,1.28) | <0.001 | 0.99 (0.88,1.12) | 0.888 |
C-Reactive Protein (Admission) | 1.01 (1.00,1.01) | <0.001 | 1.00 (1.00,1.01) | 0.171 |
Acute Kidney Injury (Admission) | 9.99 (3.34,29.9) | <0.001 | 5.75 (1.25,26.44) | 0.025 |
Lactate (Admission) | 1.85 (1.42,2.43) | <0.001 | 1.49 (1.07,2.08) | 0.017 |
Acidosis (Admission) | 17.7 (4.36,71.8) | <0.001 | 1.77 (0.16,19.9) | 0.643 |
NELA Score | 1.04 (1.00,1.09) | 0.067 | 1.03 (1.00,1.05) | 0.042 |
Clinical Diagnosis | ||||
Appendicitis | 0.00 (0.00,0.00) | 0.996 | ||
Biliary Pathology | 0.73 (0.16,3.32) | 0.682 | ||
Diverticular Disease | 1.70 (0.21,14.0) | 0.621 | ||
Gastrointestinal Bleeding | 0.00 (0.00,0.00) | 0.999 | ||
Gastrointestinal Cancer | 8.67 (2.41,31.2) | 0.001 | 7.04 (0.54,91.5) | 0.136 |
Gastrointestinal Perforation | 21.6 (6.90,67.4) | <0.001 | 13.8 (2.75,69.7) | 0.001 |
Hernia | 0.00 (0.00,0.00) | 0.997 | ||
Inflammatory Bowel Disease/Colitis | 0.00 (0.00,0.00) | 0.998 | ||
Obstruction | 0.66 (0.08,5.22) | 0.696 | ||
Ischaemic Bowel | 12.2 (2.71,54.6) | 0.001 | 13.8 (1.27,150) | 0.031 |
Non-Specific Abdominal Pain | 0.00 (0.00,0.00) | 0.998 | ||
Non-Surgical Diagnosis | 1.68 (0.36,7.87) | 0.510 | ||
Other Relevant Surgical Pathology | 0.00 (0.00,0.00) | 0.998 | ||
Pancreatitis | 0.82 (0.10,6.47) | 0.847 | ||
Peptic Ulcer Disease | 1.05 (0.13,8.41) | 0.964 | ||
Superficial Infection/Abscess | 0.00 (0.00,0.00) | 0.997 | ||
Trauma | 0.00 (0.00,0.00) | 0.997 | ||
Patient Management | ||||
Imaging | 0.00 (0.00,0.00) | 0.997 | ||
Endoscopic Intervention | 1.70 (0.21,14.0) | 0.621 | ||
Radiological Intervention | 2.97 (0.34,25.8) | 0.324 | ||
Operative Intervention | 0.73 (0.23,2.35) | 0.599 | ||
Operative Severity | ||||
Minor | 1.00 | |||
Moderate | 0.00 (0.00,0.00) | 0.997 | ||
Major/Complex Major | 1.95 (0.520,7.36) | 0.321 | ||
Operative Approach | ||||
Laparoscopic | 1.00 | |||
Open | 2.00 (0.53,7.51) | 0.304 |
OR = Odds ratio. 95% CI = 95% Confidence Interval. BAME, Black Asian and Minority Ethnic; BMI, Body Mass Index; ASA, American Society of Anesthesiologists; NEWS, National Early Warning Score; NELA, National Emergency Laparotomy Audit.